- Home
- AKRO vs ABR Comparison
AKRO vs ABR Comparison
Compare AKRO & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- ABR
- Stock Information
- Founded
- AKRO 2017
- ABR 2003
- Country
- AKRO United States
- ABR United States
- Employees
- AKRO N/A
- ABR N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- ABR Real Estate Investment Trusts
- Sector
- AKRO Health Care
- ABR Real Estate
- Exchange
- AKRO Nasdaq
- ABR Nasdaq
- Market Cap
- AKRO 2.8B
- ABR 2.3B
- IPO Year
- AKRO 2019
- ABR 2004
- Fundamental
- Price
- AKRO $39.85
- ABR $10.37
- Analyst Decision
- AKRO Strong Buy
- ABR Hold
- Analyst Count
- AKRO 9
- ABR 5
- Target Price
- AKRO $76.29
- ABR $12.13
- AVG Volume (30 Days)
- AKRO 1.1M
- ABR 3.6M
- Earning Date
- AKRO 05-16-2025
- ABR 05-02-2025
- Dividend Yield
- AKRO N/A
- ABR 15.36%
- EPS Growth
- AKRO N/A
- ABR N/A
- EPS
- AKRO N/A
- ABR 1.03
- Revenue
- AKRO N/A
- ABR $612,893,000.00
- Revenue This Year
- AKRO N/A
- ABR N/A
- Revenue Next Year
- AKRO N/A
- ABR $5.67
- P/E Ratio
- AKRO N/A
- ABR $10.09
- Revenue Growth
- AKRO N/A
- ABR N/A
- 52 Week Low
- AKRO $17.86
- ABR $9.66
- 52 Week High
- AKRO $58.40
- ABR $15.94
- Technical
- Relative Strength Index (RSI)
- AKRO 44.56
- ABR 37.57
- Support Level
- AKRO $41.60
- ABR $9.95
- Resistance Level
- AKRO $46.47
- ABR $10.54
- Average True Range (ATR)
- AKRO 2.26
- ABR 0.40
- MACD
- AKRO 0.08
- ABR -0.05
- Stochastic Oscillator
- AKRO 21.84
- ABR 23.58
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About ABR Arbor Realty Trust
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.